000 01251 a2200409 4500
005 20250513043232.0
264 0 _c19950712
008 199507s 0 0 eng d
022 _a1660-8151
024 7 _a10.1159/000188514
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlmond, M K
245 0 0 _aAvoiding acyclovir neurotoxicity in patients with chronic renal failure undergoing haemodialysis.
_h[electronic resource]
260 _bNephron
_c1995
300 _a428-32 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcyclovir
_xadministration & dosage
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aComputer Simulation
650 0 4 _aFemale
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xcomplications
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNervous System
_xdrug effects
650 0 4 _aRenal Dialysis
650 0 4 _aVirus Diseases
_xcomplications
700 1 _aFan, S
700 1 _aDhillon, S
700 1 _aPollock, A M
700 1 _aRaftery, M J
773 0 _tNephron
_gvol. 69
_gno. 4
_gp. 428-32
856 4 0 _uhttps://doi.org/10.1159/000188514
_zAvailable from publisher's website
999 _c7776471
_d7776471